Acoustic Neuroma Market is segmented By Diagnosis (Imaging Techniques, Audiometry, Electrophysiology), By Treatment (Observation, Surgery, Radiation T....
Market Size in USD
CAGR9.1%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 9.1% |
Market Concentration | High |
Major Players | Amgen, Roche, Natus Medical Incorporated, Elekta, Pfizer Inc. |
The acoustic neuroma market is estimated to be valued at USD 2.29 Bn in 2024 and is expected to reach USD 4.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9% from 2024 to 2031.
Factors such as rising awareness regarding early disease diagnosis and available treatment options, technological advancements in neurotology devices and imaging technologies, and increasing healthcare expenditure are expected to drive the acoustic neuroma market during the forecast period.